Arbe Robotics Ltd. (NASDAQ: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, today announced financial results for its first quarter fiscal year 2022, ended March 31, 2022.
Key Q1 2022 Highlights:
"It's an exciting time to be in the automotive industry," said Kobi Marenko, Chief Executive Officer. "We are making great progress with Tier-1s as well as with our customers who appreciate the benefits of our imaging radar technology, overcoming the shortcomings of traditional radars. With the launch of our final RF chipset production configuration, we can provide the highest level of performance and safety to all automotive verticals, including passenger vehicles, commercial vehicles, trucks and delivery robots."
"Additionally, we are delighted to be able to attract industry veterans Thilo Koslowski and Alex Hitzinger as new Arbe board members and Gonen Barkan as our Chief Radar Officer. Their commitment to Arbe is a strong vote of confidence in our future. Combined with our recent industry recognition and awards, these are important milestones that we are on the right path and progressing according to plan," concluded Kobi Marenko.
First Quarter 2022 Financial Highlights
Revenues for Q1 2022 were $0.9 million, an increase from $0.6 million in Q1 2021. Backlog as of March 31, 2022, was $2.8 million.
Gross margin for Q1 2022 was 56.1%, compared to 44.3% in Q1 2021, mainly related to a decrease in cost as we worked toward production versions.
Operating expenses in Q1 were $11.1 million, compared to $4.5 million in Q1 2021. The increase in operating expenses was primarily driven by an increase in research and development expenses from $3.7 million in Q1 2021 to $7.8 million in Q1 2022. The increase was most notably in labor cost and to a lesser extent non-cash share-based compensation expenses. As a result, our operating loss increased from $4.3 million to $10.6 million.
Net loss in the first quarter of 2022 decreased significantly to $7.9 million compared to a net loss of $18.4 million in the first quarter of 2021. The net loss in Q1 2022 reflected financial income of $2.8 million as contrasted with financial expense of $14.1 million in Q1 2021. Both years' financial expenses/income related to the revaluations of convertible loan and warrants.
Adjusted EBITDA in Q1 of 2022, a non-GAAP measurement which excludes financial expense/income and expenses for non-cash share-based compensation and for non-recurring public offering expenses, yielded a loss of ($8.6) million, compared with a loss of ($4.1) million in the first quarter of 2021.
Balance Sheet & Liquidity
As of March 31, 2022, Arbe had $87.3 million in cash and cash equivalents. Total debt on March 31, 2022, was $5.1 million which we expect to pay by July 1, 2022.
Outlook
Management reiterated the outlook for the full year ending December 31, 2022. Based on current estimates, management expects:
Earnings Call Details
Arbe will review the financial results in more detail today at 11:00 a.m. Eastern Time, followed by an insightful fireside chat about the promises and challenges of automotive autonomy over the next decade, and will conclude with a question-and-answer session.
Please register here to receive the Zoom link or from Arbe's Investor Relations website at https://ir.arberobotics.com. An archived webcast of the conference call will also be made available on the website following the call.
About Arbe
Arbe (NASDAQ: ARBE), a global leader in next-generation 4D Imaging Radar Chipset Solutions, is spearheading a radar revolution, enabling truly safe driver-assisted systems today while paving the way to full autonomous driving. Arbe's imaging radar is 100 times more detailed than any other radar on the market and is a mandatory sensor for Level 2+ and higher autonomy. The company is empowering automakers, Tier 1 suppliers, autonomous ground vehicles, commercial and industrial vehicles, and a wide array of safety applications with advanced sensing and paradigm-changing perception. Arbe is a leader in the fast-growing automotive radar market that has a projected total addressable market of an estimated $11 billion in 2025. Arbe is based in Tel Aviv, Israel, and has an office in the United States.
Cautionary Note Regarding Forward-Looking Statements
This press release and earnings call, including the fireside chat, may contain "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words "expect," "believe," "estimate," "intend," "plan," "anticipate," "project," "may," "should," "strategy," "future," "will," "project," "potential" and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Statements that are not historical facts, including any statements that are made at the investor and analyst event described in this press release, are forward-looking statements. The financial results described in this press release are based on Arbe's unaudited financial statements, which have not been reviewed by the independent auditors. These risks and uncertainties include, but are not limited to: (i) unanticipated delays or difficulties in receiving and processing orders; (ii) Arbe's ability to develop significant revenue as a result of its relationships with OEM and Tier 1s, (iii) Arbe's ability to leverage its existing relationships and secure test programs and orders resulting from the test programs; (iv) Arbe's ability to meet its projected revenue level and its ability to operate profitably; (v) Arbe's ability to meet is timetable for full production; (v) Arbe's expectation that it will be engaging with Tier 1 suppliers and OEMs which would be building the radars based on its Chipset solution, eliminating expenses associated with system completion, requirement for undertaking significant capital expenditures associated with developing mass production manufacturing and the expenses of operating any such manufacturing capability; (vii) the effect of inflation and supply chain issues on Arbe's cost and its development schedule, including Arbe's ability to obtain semiconductor products when needed and at a reasonable price; (viii) Arbe's expectation that radars are crucial to the automotive industry and will be deployed in nearly all new vehicles as a long range, cost-effective sensor with the fewest environmental limitations; (ix) Arbe's belief that its Radar Chipset heralds a breakthrough in radar technology that will enable Tier 1 manufacturers and OEMs to replace the current radars with an advanced solution that meets the safety requirements of Euro-NCAP and NHTSA for autonomous vehicles at all levels of autonomous driving; (x) Arbe's ability to develop or have access to the latest developments relating to radar and autonomous driving vehicles; (xi) Arbe's ability to have products manufactured for it by third parties that meet Arbe's and its customers quality standards and delivery requirements; (xii) Arbe's ability to attract and retain highly skilled personnel and senior management, including research and development, sales and marketing personnel; (xiii) Arbe's ability to develop and market products based on its radar technology for uses outside of the automotive industry; (xiv) accidents or bad press resulting from accidents involving autonomous driving vehicles, even those using radar products from other companies or based on other technology; and the effect of any accidents with vehicles using Arbe's radar system; (xv) the failure of the markets for Arbe's current or new technologies and products to materialize to the extent or at the rate that Arbe expects; (xvi) unexpected delays or difficulties related to the development of Arbe's technologies and products; (xvii) the effect of laws and changes in laws that have an effect on the market for or the requirement for autonomous vehicles; (xviii) the effect of COVID-19 and any new variants or any pandemics or multinational epidemics and actions taken by governments and industry to address the effects of the pandemic and the corresponding macroeconomic uncertainty; (xviii) risks related international conflicts and terrorist events, including those which may involve Israel; (xix) changes or inaccuracies in market projections; (xx) changes in Arbe's business strategy; and (xxi) the risk factors and uncertainties described in "Risk Factors," "Operating and Financial Review and Prospects" "Cautionary Note Regarding Forward-Looking Statements" and the additional risk described in Arbe's annual report on Form 20-F, as well as the other documents filed by Arbe with the SEC and any documents which are filed by Arbe. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and Arbe does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.
CONSOLIDATED BALANCE SHEETS | ||||||||
(U.S. dollars in thousands) | ||||||||
March 31, | December 31, | |||||||
Current Assets: | (Unaudited) | (Audited) | ||||||
Cash and cash equivalents | 87,255 | 100,811 | ||||||
Restricted cash | 132 | 125 | ||||||
Short term bank deposits | 400 | - | ||||||
Trade Receivable | 653 | 187 | ||||||
Prepaid expenses and other receivables | 3,397 | 3,058 | ||||||
Total current assets | 91,837 | 104,181 | ||||||
Non-Current Assets | ||||||||
Operating lease right-of-use assets | 738 | - | ||||||
Property and equipment, net | 1,375 | 1,165 | ||||||
Total non-current assets | 2,113 | 1,165 | ||||||
Total assets | 93,950 | 105,346 | ||||||
Current liabilities: | ||||||||
Short term loan | 5,063 | 4,916 | ||||||
Trade payables | 1,412 | 2,005 | ||||||
Operating lease liabilities | 396 | - | ||||||
Employees and payroll accruals | 3,467 | 3,095 | ||||||
Deferred revenues | 731 | 726 | ||||||
Accrued expenses and other payables | 1,860 | 4,725 | ||||||
Total current liabilities | 12,929 | 15,467 | ||||||
Long term liabilities | ||||||||
Operating lease liabilities | 326 | |||||||
Warrant Liability | 6,774 | 10,056 | ||||||
Total long-term liabilities | 7,100 | 10,056 | ||||||
SHAREHOLDERS' EQUITY: | ||||||||
Ordinary Shares | *) | *) | ||||||
Additional paid-in capital | 201,423 | 199,469 | ||||||
Accumulated Deficit | (127,502) | (119,646) | ||||||
Total shareholders' equity | 73,921 | 79,823 | ||||||
Total liabilities and shareholders' equity | 93,950 | 105,346 | ||||||
*) | Represents less than $1. |
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
(U.S. dollars in thousands, except share and per share data) | ||||||||
3 Months | 3 Months | |||||||
March 31, | March 31, | |||||||
(Unaudited) | (Unaudited) | |||||||
Revenues | 876 | 580 | ||||||
Cost of revenues | 384 | 323 | ||||||
Gross Profit | 492 | 257 | ||||||
Operating Expenses: | ||||||||
Research and development, net | 7,803 | 3,711 | ||||||
Sales and marketing | 1,182 | 295 | ||||||
General and administrative | 2,145 | 521 | ||||||
Total operating expenses | 11,130 | 4,527 | ||||||
Operating loss | (10,638) | (4,270) | ||||||
Financial expenses (Income), net | (2,782) | 14,106 | ||||||
Net loss | (7,856) | (18,376) | ||||||
Basic and diluted net loss per share | (0.12) | (1.98) | ||||||
Weighted-average number of shares used in | 63,034,545 | 9,300,548 | ||||||
* | The number of ordinary shares retroactively reflects the 46.25783-for-one |
2
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(U.S. dollars in thousands) | ||||||||
3 Months | 3 Months | |||||||
March 31, | March 31, | |||||||
Cash flows from operating activities: | (Unaudited) | (Unaudited) | ||||||
Net Loss | (7,856) | (18,376) | ||||||
Adjustments to reconcile loss to net cash used in operating activities: | ||||||||
Depreciation | 105 | 53 | ||||||
Stock-based compensation | 1,790 | 146 | ||||||
Warrants to service providers | 69 | 19 | ||||||
Revaluation of warrants and accretion | (3,135) | 3,275 | ||||||
Revaluation of convertible loan | - | 10,762 | ||||||
Change in operating assets and liabilities: | ||||||||
Increase in trade receivable | (465) | (271) | ||||||
Increase in prepaid expenses and other receivables | (339) | (219) | ||||||
Operating lease ROU assets and liabilities, net | (16) | - | ||||||
Increase (decrease) in trade payables | (668) | 66 | ||||||
Increase in employees and payroll accruals | 372 | 105 | ||||||
Increase in deferred revenue | 5 | 34 | ||||||
Increase (decrease) in accrued expenses and other payables | (2,865) | 364 | ||||||
Net cash used in operating activities | (13,003) | (4,042) | ||||||
Cash flows from investing activities: | ||||||||
Change in bank deposits | (400) | - | ||||||
Purchase of property and equipment | (242) | (340) | ||||||
Net cash used in investing activities | (642) | (340) | ||||||
Cash flows from financing activities: | ||||||||
Repayment of long-term loan | - | (451) | ||||||
Proceeds from exercise of warrants | - | 2,440 | ||||||
Proceeds from exercise of options | 96 | 34 | ||||||
Proceeds from convertible loan | - | 11,337 | ||||||
Net cash provided by financing activities | 96 | 13,360 | ||||||
Increase (decrease) in cash, cash equivalents and restricted cash | (13,549) | 8,978 | ||||||
Cash, cash equivalents and restricted cash at the beginning of the year | 100,936 | 2,954 | ||||||
Cash, cash equivalents and restricted cash at the end of the period | 87,387 | 11,932 |
3
RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS | ||||||||
(U.S. dollars in thousands, except share and per share data) | ||||||||
3 Months | 3 Months | |||||||
March 31, | March 31, | |||||||
(Unaudited) | (Unaudited) | |||||||
GAAP net loss attributable to ordinary shareholders | (7,856) | (18,376) | ||||||
Add: | ||||||||
Stock-based compensation | 1,790 | 146 | ||||||
Warrants to service providers | 69 | 19 | ||||||
Revaluation of warrants and accretion | (3,135) | 3,275 | ||||||
Revaluation of convertible loan | - | 10,762 | ||||||
Non-recurring initial public offering expenses | 130 | - | ||||||
Non-GAAP net loss | (9,002) | (4,174) | ||||||
Basic and diluted Non-GAAP net loss per share | (0.14) | (0.45) | ||||||
Weighted-average number of shares used in computing | 63,034,545 | 9,300,548 | ||||||
* | The number of ordinary shares retroactively reflects the 46.25783-for-one |
RECONCILIATION OF GAAP NET LOSS TO AJUSTED EBITDA | ||||||||
(U.S. dollars in thousands) | ||||||||
3 Months | 3 Months | |||||||
March 31, | March 31, | |||||||
(Unaudited) | (Unaudited) | |||||||
GAAP net loss attributable to ordinary shareholders | (7,856) | (18,376) | ||||||
Add: | ||||||||
Financial expenses, net | (2,782) | 14,106 | ||||||
Depreciation | 105 | 53 | ||||||
Stock-based compensation | 1,790 | 146 | ||||||
Warrants to service providers | 69 | 19 | ||||||
Non-recurring initial public offering expenses | 130 | - | ||||||
Adjusted EBITDA | (8,544) | (4,052) |
Last Trade: | US$1.91 |
Daily Change: | -0.03 -1.30 |
Daily Volume: | 267,485 |
Market Cap: | US$154.130M |
November 04, 2024 September 26, 2024 September 04, 2024 August 06, 2024 July 11, 2024 |
DevvStream provides upfront capital for sustainability projects in exchange for carbon credit rights. Through these rights, the company generates and manages carbon credits by utilizing the most technologically advanced...
CLICK TO LEARN MORENorthstar Clean Technologies is a cleantech company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar’s mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS